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Abstract
Background: Hospital-initiated smoking cessation interventions utilizing pharmacotherapy increase post-discharge
quit rates. Use of smoking cessation medications following discharge may further increase quit rates. This study
aims to identify individual, smoking-related and hospitalization-related predictors of engagement in three different
steps in the smoking cessation pharmacotherapy utilization process: 1) receiving medications as inpatient, 2) being
discharged with a prescription and 3) using medications at 1-month post-hospitalization, while accounting for
associations between these steps.
Methods: Study data come from a clinical trial (N = 1054) of hospitalized smokers interested in quitting who were
randomized to recieve referral to a quitline via either warm handoff or fax. Variables were from the electronic health
record, the state tobacco quitline, and participant self-report. Relationships among the predictors and the steps in
cessation medication utilization were assessed using bivariate analyses and multivariable path analysis.
Results: Twenty-eight percent of patients reported using medication at 1-month post-discharge. Receipt of
smoking cessation medications while hospitalized (OR = 2.09, 95%CI [1.39, 3.15], p < .001) and discharge with a script
(OR = 4.88, 95%CI [3.34, 7.13], p < .001) were independently associated with medication use at 1-month post-
hospitalization. The path analysis also revealed that the likelihood of being discharged with a script was strongly
influenced by receipt of medication as an inpatient (OR = 6.61, 95%CI [4.66, 9.38], p < .001). A number of other
treatment- and individual-level factors were associated with medication use in the hospital, receipt of a script, and
use post-discharge.
Conclusions: To encourage post-discharge smoking cessation medication use, concerted effort should be made to
engage smokers in tobacco treatment while in hospital. The individual and hospital-level factors associated with
each step in the medication utilization process provide good potential targets for future implementation research
to optimize treatment delivery and outcomes.
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Background
The rate of smoking among hospitalized patients (40%)
exceeds that of the general population (13%) [1], suggest-
ing that inpatient smokers are an important target for to-
bacco treatment intervention. Hospital-based treatment
for tobacco dependence is effective [2]. Interventions that
start in hospital and provide supportive contact for at least
one-month post discharge increase quit rates by 37% [2].
Medications started during hospital stays are also effective
for smoking cessation; a Cochrane review found that add-
ing nicotine replacement therapy (NRT) to supportive in-
patient intervention increased quit rates by 54% [2], and a
recent clinical trial found that free NRT provided at dis-
charge significantly increased quit rates independent of
behavioral support [3]. Few hospitals, however, routinely
provide or prescribe cessation medications to their pa-
tients. Freund et al. found that only 13% of hospital pro-
viders reported they offered or advised the use of
cessation medications [4].
Hospital and patient-level factors influence patients’
pharmacotherapy use. Regan et al., 2012 found that
smokers who received NRT during hospitalization were
more likely to use it after discharge compared with those
who did not use NRT in hospital [5]. Chui et al., 2018
found that predictors of NRT use among hospitalized
smokers during their hospital stay and at discharge in-
cluded heavy smoking and expressing interest in NRT for
their next quit attempt [6]. Smokers who were admitted
for a respiratory or cardiac problem were more likely to
use a cessation medication at discharge [6]. Although
these previous studies show that patient characteristics are
associated with smoking cessation pharmacotherapy use,
the process of how patients do or do not receive pharma-
cotherapy in hospital and prescriptions on discharge is un-
clear. Few studies have examined barriers to or facilitators
of cessation pharmacotherapy administration in hospitals
and use post-hospitalization [5–8]. Further, no studies
have examined predictors of getting a prescription for ces-
sation medication at hospital discharge.
Hospital systems of care could facilitate pharmacother-
apy utilization. Medication reconciliation, a process that
identifies patients’ current medications and is designed to
improve quality and continuity of medication manage-
ment [9], might influence the tobacco cessation pharma-
cotherapy process by carrying forward any current
cessation prescriptions through the admission and dis-
charge processes. Prior studies do not account for the
causal relationships that the medication reconciliation
process creates between receipt of medication in the hos-
pital, receipt of a script on discharge, and utilization of
medication post-discharge.
Insight into the factors that influence use of medica-
tions post-discharge may help hospital providers provide
better care. The present study examines pathways and
predictors of medication use at 1-month post-discharge.
We used a multivariable path analysis to isolate the in-
dependent effects of a number of patient, hospitalization
and smoking-related variables as well as the effects of
factors in the medication reconciliation and prescribing
process (such as using medications prior to admission,
receiving medications as an inpatient, and receiving a
script for medications on discharge).
Methods
Design and setting
This study is a secondary analysis of data from a clinical
trial in which hospital inpatient smokers were randomized
to either warm handoff or fax-referral for enrollment in
state tobacco quitline services [10, 11]. The fax-referral
arm was the usual tobacco treatment care provided by the
hospital tobacco treatment staff. It consisted of a) asses-
sing withdrawal; b) adjusting inpatient nicotine replace-
ment to enhance patient comfort; c) arranging medication
prescriptions on discharge; and d) developing a quit plan.
Staff fax-referred patients to the quitline on the day they
were discharged from the hospital. In the warm handoff
arm, staff conducted usual care steps a-c, then immedi-
ately linked patients with the quitline via telephone for
registration and completion of a quit plan with the quit-
line provider. Participants were enrolled in two Kansas
hospitals with dedicated tobacco treatment intervention-
ists on staff. Informed consent was obtained for all
participants. The institutional review boards at both hos-
pitals approved study protocols and measures.
Participants and procedures
Eligible participants were planning to stay quit
post-discharge, smoked within the past 30 days and were 18
years and older. Additional eligibility criteria and study pro-
cedures are reported elsewhere [10, 11]. Participants were
identified through the electronic health record (EHR) and
consented at bedside. Both study arms involved bedside to-
bacco treatment that included a smoking cessation booklet,
discussing withdrawal symptoms, gauging interest in smok-
ing cessation medications, and arranging for medication
scripts both in the hospital and on discharge. No medica-
tions were provided as part of the study and prescribing hos-
pital physicians were not part of the study team. In the warm
handoff arm, study counselors called the quitline and trans-
ferred the call to the patients’ mobile or bedside hospital
phone for enrollment and an initial counseling session; in
fax-referral, counselors faxed an enrollment form to the quit-
line upon patient discharge.
Measures
Patient-level measures
Variables from the baseline study survey included race,
ethnicity and highest level of education. Patient birth
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date, sex and health insurance status were collected from
the EHR. International Classification of Diseases-9
(ICD-9) codes were used for primary and secondary dis-
charge diagnoses. Primary diagnoses were grouped into
the major ICD-9 categories. We used a defined list of
ICD-9 codes to identify patients with tobacco-related
diseases [12]. Primary or secondary psychiatric disorders
were indicated by ICD-9 codes 290–319, excluding 305.1
for tobacco use disorder.
Smoking-related measures
Variables related to patient smoking characteristics or to-
bacco treatment included the Heaviness of Smoking Index
(HSI) [13], ,confidence in quitting/staying quit, and previ-
ous use of smoking cessation medications. Confidence in
quitting was assessed by the item, “How confident are you
that you will be able to quit/stay quit once you are dis-
charged from the hospital?” The item was scored on a 1
(Not at all confident) to 5 (very confident) scale. Total
quitline counseling calls was also collected for each par-
ticipant and was provided by Optum, the state quitline
contractor and a subcontractor on the project.
Hospitalization-related measures
Hospital length of stay in hours and whether or not the
patient was admitted through the emergency department
were collected from the EHR.
Smoking cessation pharmacotherapy utilization outcomes
We collected data on three potentially interrelated
dependent variables related to cessation medications. Two
were collected from the EHR: receipt of smoking cessation
medication (NRT, bupropion, or varenicline) in-hospital
and whether a prescription, or script, for smoking cessa-
tion medication was provided at discharge. The third vari-
able—self-reported use of smoking cessation medication
at 1-month post-discharge—was collected from partici-
pants via telephone survey.
Statistical analysis
We included 984 of the original 1054 participants in this
study who were reached for 1-month follow-up (93.4%
of all participants). Path analysis was used to assess the
conditional relationships of the independent variables
and the three dependent medication-related variables.
Path analysis uses a system of equations to test the via-
bility of a multivariable theoretical or conceptual model
and is akin to structural equation modeling with ob-
served variables. Because path analysis is based upon a
system of equations, it offers the ability to efficiently de-
compose covariation among a set of independent (i.e.,
exogenous) and dependent (i.e., endogenous). As result,
path analysis can be used to test hypothesized direct and
indirect effects [14].
For the path analysis, the three dependent variables
(receipt of pharmacotherapy while inpatient, discharge
with a script for pharmacotherapy) were simultan-
eously regressed on a set of patient, smoking-related
and hospitalization-related predictors. To account for
interrelationships among the dependent variables, be-
ing discharged with a script was regressed on receipt
of medication while inpatient and medication use at
1-month was regressed on discharge with a script for
medication and receipt of medication while hospital-
ized. The path model is visually depicted in Fig. 1. The
multivariable path analysis was estimated in Mplus,
version 7.4 [15] using robust maximum likelihood
(MLR) and Bayesian multiple imputation to account
for missing data [16, 17].
Results
Relationships between medication outcomes
Twenty-eight percent (264/935) of the sample reported
using medication at 1-month post-discharge. Twenty-four
percent of participants received pharmacotherapy as an
inpatient and 31% were discharged with a prescription. Of
the participants who reported using pharmacotherapy at
1-month post-discharge, 60.5% were discharged with a
prescription for medication and 43.6% received medica-
tion while hospitalized. The majority of patients dis-
charged with a script for medication (51.5%) had received
medication while hospitalized.
Bivariate predictors of medication outcomes
Self-reported use of medication at 1-month was associ-
ated with older age, being in the fax-referral arm, shorter
length of stay, tobacco related disease, nicotine depend-
ence, previously using cessation medication and
completing more counseling calls (Table 1). Being dis-
charged with a script was also associated with depend-
ence and previous medication use, but also with ED
admission, psychiatric diagnosis and lower confidence in
ability to quit. Lastly, using medication while inpatient
was associated with a similar set of variables as the other
outcomes, however with more robust effects of ED ad-
mission (Odds Ratio (OR) = 1.93, 95%CI [1.42, 2.66], p
< .001) and psychiatric diagnosis (OR = 1.82, 95%CI
[1.34, 2.45], p < .001). The statistically significant rela-
tionships shown in Table 1 suggest that using cessation
medication while hospitalized, being discharged with a
script and using medication at 1-month are influenced
by a partially overlapping set of patient, hospitalization
and smoking-realted factors, which we tested in a multi-
variable path analysis.
Path analysis
Table 2 presents the results from the multivariable path
analysis. Being discharged with a script for medication
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Fig. 1 Schematic diagram for study path analysis
The bulleted variables correspond to the independent variables in the model and the three medication-related variables correspond to the
dependent variables. All arrows denote regression. In addition, each bulleted variable is a predictor of its respective outcome variable.
Note. ED = Emergency department, HSI = Heaviness of Smoking Index
Table 1 Descriptive Statistics by Cessation Medication Use Outcome and Odds Ratios
Received Meds Inpatient Discharged with Script Used Meds at 1-Month
24.4% (239/978) 95% CI 31.2% (305/979) 95% CI 28.2% (264/935) 95% CI
OR LL UL OR LL UL OR LL UL
Study arm, N (%) 115 (48.12) 0.86 0.64 1.15 152(49.84) 0.93 0.71 1.22 116 (43.94) 0.7 0.52 0.93*
Age (years), mean (SD) 49.71(13.19) 1 0.99 1.01 50.51 (12.34) 1.01 1 1.02 51.34 (12.13) 1.01 1 1.02*
Female, N (%) 141 (59) 1.21 0.9 1.62 182 (59.67) 1.28 0.98 1.69 157 (59.47) 1.22 0.92 1.64
Edu. > HS, N (%) 130 (54.39) 1.15 0.86 1.54 149 (48.85) 0.85 0.65 1.11 138 (52.27) 1.02 0.76 1.35
Hispanic, N (%) 13 (5.49) 0.85 0.44 1.56 18 (5.96) 0.95 0.53 1.65 13 (4.94) 0.8 0.4 1.47
White, N (%) 178 (74.48) 1.29 0.93 1.8 219 (71.8) 1.07 0.8 1.45 195 (73.86) 1.26 0.92 1.74
Insurance, N (%)
Self-Pay 9 (3.77) 0.58 0.26 1.14 10 (3.28) 0.47 0.22 0.92* 15 (5.68) 1.03 0.54 1.88
Medicare 85 (35.56) 1.46 1.07 1.98* 103 (33.77) 1.34 1 1.79 82 (31.06) 1.09 0.8 1.48
Medicaid 78 (32.64) 0.89 0.65 1.21 113 (37.05) 1.17 0.88 1.56 96 (36.36) 1.06 0.79 1.42
Private/VA 67 (28.03) 0.87 0.63 1.2 79 (25.9) 0.73 0.54 0.99* 71 (26.89) 0.85 0.62 1.16
Admitted through ED, N (%) 170 (71.13) 1.93 1.42 2.66*** 197 (64.59) 1.37 1.04 1.82* 168 (63.64) 1.26 0.94 1.7
Length of stay in hoursa, median (IQR) 86.35 (81.75) 0.82 0.55 1.24 92.08 (87.7) 0.86 0.59 1.25 84.44 (92.06) 0.65 0.44 0.96*
Smoking related disease, N (%) 110 (46.03) 1.31 0.98 1.76 141 (46.23) 1.34 1.02 1.77* 124 (46.97) 1.4 1.05 1.87*
Psych. diagnosis, N (%) 104 (43.51) 1.82 1.34 2.45*** 118 (38.69) 1.43 1.08 1.9* 78 (29.55) 0.82 0.6 1.11
HSI, mean (SD) 3.11 (1.53) 1.23 1.12 1.35*** 3.12 (1.51) 1.26 1.16 1.37*** 3.03 (1.59) 1.2 1.09 1.31***
Pre-admission Meds, N (%) 155 (64.85) 2.08 1.54 2.83*** 196 (64.26) 2.16 1.64 2.86*** 180 (68.18) 2.65 1.97 3.59***
Total counselling calls, median(IQR) 1(3) 1 0.92 1.09 1 (3) 1.04 0.96 1.13 2 (4) 1.16 1.07 1.26***
Confidence, mean (SD) 3.5 (1.13) 0.74 0.65 0.85*** 3.67 (1.14) 0.87 0.77 0.98* 3.71 (1.07) 0.92 0.81 1.04
Inpatient Meds, N (%) – – – – 157 (51.48) 7.73 5.61 10.71*** 115 (43.56) 3.66 2.67 5.02***
Discharged with script for Meds, N (%) – – – – – – – – 159 (60.46) 6.25 4.59 8.57***
NRT nicotine replacement therapy, ED emergency department, IQR interquartile range, HS high school, OR odds ratio, HSI Heaviness of Smoking Index,
SD standard deviation, VA Veterans Administration, CI confidence interval, LL lower limit, UL upper limit, Meds = Smoking Cessation Medications
(nicotine replacement, bupropion, or varenicline)
* p < .05; ** p < .01; *** p < .001
aLog(Length of stay) is used in bivariate analyses
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(OR = 4.88, 95%CI [3.34, 7.13], p < .001) and using medi-
cation while inpatient (OR = 2.09, 95%CI [1.39, 3.15], p
< .001) were independently associated with using medi-
cation at 1-month. Using cessation medication as an in-
patient was robustly associated with being discharged
with a script (OR = 6.61, 95%CI [4.66, 9.38], p < .001).
Use of medication while inpatient was associated with ad-
mission through the ED, having a psychiatric diagnosis, nico-
tine dependence, past smoking cessation medication use and
lower confidence in ability to quit. After controlling for medi-
cation use while inpatient, nicotine dependence and past
medication use were the only factors with significant odds of
being discharged with a script for medication. After control-
ling for the effects of a) receiving inpatient pharmacotherapy
and b) being discharged with a script for medication, the like-
lihood of medication use at 1-month was associated with a
shorter length of stay, not having a psychiatric diagnosis,
using medication prior to hospitalization and engagement in
a greater number of counselling sessions post-hospitalization.
Discussion
Our findings demonstrate that receiving smoking cessa-
tion medication as an inpatient and being discharged
with a script for medication are each independently as-
sociated with patients’ utilization of pharmocotherapy at
1-month post-hospitalization. These effects were robust
after accounting for both individual and treatment re-
lated factors.
The present study extends the literature by accounting
for the causal pathway of medication provision. Specific-
ally, we examined discharge with a script for medication
as both a dependent variable and a predictor of cessation
medication use post-discharge. The likelihood of being
discharged with a script was strongly influenced by re-
ceipt of medication as an inpatient and was robustly as-
sociated with medication use at follow-up. The strength
of this association suggests a high degree of continuity
between leaving the hospital with a script and ultimately
using medication post-discharge. Implementation re-
search on how to increase the rate of provision of scripts
for cessation medication during discharge and how to
increase the likelihood that these scripts are filled may
lead to greater medication utilization, and in turn, im-
proved quit rates among recently hospitalized smokers.
Hospital-initiated smoking cessation interventions are
most effective when they extend 1-month post-discharge
Table 2 Model Results from Multivariable Path Analysis of Steps in Cessation Pharmacotherapy Engagement
Received Meds Inpatient Discharged with Script Used Meds at 1-Month
OR 95% CI OR 95% CI OR 95% CI
Predictor LL UL LL UL LL UL
Warm handoff 0.92 0.67 1.25 1.02 0.75 1.38 0.57 0.41 0.79**
Age, years 0.99 0.97 1 1 0.99 1.01 1.01 0.99 1.02
Female 1 0.73 1.37 1.06 0.77 1.46 0.92 0.65 1.30
Hispanic 1.12 0.56 2.22 1.26 0.69 2.32 1.01 0.47 2.15
White race 1 0.68 1.46 0.77 0.54 1.10 1.20 0.80 1.80
Insurance
None 0.51 0.23 1.14 0.60 0.26 1.39 1.94 0.94 4.01
Medicare 1.46 0.96 2.20 1.23 0.81 1.87 0.86 0.55 1.36
Medicaid 0.91 0.61 1.37 1.45 0.98 2.15 1.22 0.81 1.85
Admitted through ED 2.12 1.52 2.95*** 1.11 0.80 1.52 1.08 0.76 1.52
log(LOSa) 1.01 0.67 1.54 0.85 0.56 1.31 0.56 0.34 0.90*
Smoking related disease 1.27 0.91 1.78 1.21 0.87 1.68 1.04 0.73 1.48
Psychiatric diagnosis 1.73 1.24 1.78** 1.17 0.83 1.64 0.57 0.39 0.83**
HSI 1.21 1.09 1.34*** 1.21 1.10 1.33*** 1.06 0.95 1.19
Used meds prior to admission 2.02 1.45 2.81*** 1.82 1.30 2.55*** 2.00 1.39 2.88***
Confidence 0.80 0.70 0.92** 1.04 0.90 1.20 1 0.86 1.13
Used meds in hospital – – – 6.61 4.66 9.38*** 2.09 1.39 3.15***
Discharged with script for meds – – – – – – 4.88 3.34 7.13***
Total counselling calls – – – – – – 1.22 1.04 1.35***
NRT nicotine replacement therapy, ED emergency department, LOS length of stay, HSI Heaviness of Smoking Index, OR odds ratio, UL Upper Limit, LL lower limit,
Meds = Smoking Cessation Medications (nicotine replacement, bupropion, or varenicline)
* p < .05; ** p < .01; *** p < .001
aLength of stay is in hours
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and their efficacy is enhanced with the addition of
pharmacotherapy [2]. The multivariable model showed
that cessation medication use at 1-month was associated
with multiple factors above and beyond the medication
pathway described above. Notably, medication use was as-
sociated with greater engagement in counseling and not
having a psychiatric diagnosis. These results suggest that
counseling that is initiated in the hospital and continued
via quitline post-discharge can reinforce the use of cessa-
tion medication, which is consistent with previous research
[5, 18]. In addition, smokers with psychiatric diagnoses, or
psychosis [18], may need more intensive support in order
to facilitate treatment utilization post-hospitalization.
Findings from this study confirm those of previous
studies. Previous research has found that smoking cessa-
tion medication use prior to hospitalization [6, 8], nico-
tine dependence [6–8] and less confidence in ability to
not smoke [8] are associated with medication use while
hospitalized. Consistent with the present results,
post-discharge medication use has been associated with
inpatient medication use [5, 18], medication use prior to
hospitalization [5], shorter length of stay [5] and tobacco
related disease [6]. These results lend support to findings
from the general population in which smokers who
elected to use NRT were more nicotine dependent, less
confident in their ability to quit and generally possessed
more risk factors for cessation failure [19]. Similar to
findings from the main outcome study [10], patients re-
ceiving the warm handoff intervention were less likely to
use medications post discharge-likely because they had
shorter visits with inpatient counselors who may have,
compared to quitline counselors, put more stress on the
importance of using medications post-discharge.
In addition, this study provides additional information on
elements of the hospitalization context that may influence
the likelihood of using smoking cessation medication
post-discharge. In addition to length of stay, admission
through the ED increased the likelihood of receiving medi-
cation while hospitalized and of being discharged with medi-
cation, although the effect on discharge did not remain
significant in the multivariable analysis. One possible explan-
ation for the effect of ED admission on receipt of medication
is that waiting to be seen in the ED may function as a period
of forced abstinence, thus patients may be in withdrawal
and be more likely to request relief and/or be offered cessa-
tion medication once admitted. Other possible explanations
include: ED patients have higher smoking prevalence than
other hospital patients [20], they often present with
tobacco-related illnesses or need surgical procedures that
will require smoking abstinence for optimal wound healing
[21], and they are more likely to receive smoking cessation
treatment than non-ED patients [22]. Future research is
needed to identify other aspects of the hospitalization con-
text that influence treatment engagement.
Limitations
The present study had two major limitations. First, the re-
liance upon self-report for medication use at 1-month
raises the possibility of participant misreporting. In
addition, because intending to stay quit post-discharge
was an inclusion criterion for the study, the presented re-
sults may not be generalizable to inpatient smokers who
are not prepared to make a quit attempt. The study was
conducted in two hospitals in the U.S., which may not be
representative of community hospitals or hospitals in
other countries. In addition, hospitals that do not have
dedicated tobacco interventionists might achieve different
pharmacotherapy utilization results. For example, if ad-
vanced practice providers (APPs) such as nurse practi-
tioners took on the task of treating tobacco dependence,
inpatient utilization, discharge prescription, and hence
outpatient utilization rates could be higher because APPs
have the ability to write prescriptions for medications. The
present analysis also had several strengths, including the
relatively large sample size, the use of variables from mul-
tiple sources including the EHR, the quitline provider, and
study participants; and the use of multivariable path ana-
lyses that controlled for hospital procedures—such as
medication reconciliation at admission and discharge—
that increase the likelihood that past medication receipt
predicts future medication receipt.
Conclusions
In sum, smoking cessation medication post-discharge is in-
dependently associated with receiving medication while in-
patient and being discharged with a script for medication,
even after accounting for other hospital treatment and indi-
vidual characteristics. Continued efforts to engage hospital-
ized smokers in treatment while inpatient and in transition
from the hospital are necessary to promote sustained medi-
cation use post-hospitalization. Hospitalized smokers
intending to stay quit may be highly vulnerable to relapse
post-discharge without sustained medication use.
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